Trial · NCT03019575
Results by group100
Each measurement the trial posted, group by group, in the words and numbers it posted.
41 to 60 of 100
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in TS of Pubertal Development for Genital Growth to Week 12, Week 36, and Week 64 | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | BL Tanner I to Week 36 Tanner I | 2 | Participants | |
| Change From Baseline in TS of Pubertal Development for Genital Growth to Week 12, Week 36, and Week 64 | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | BL Tanner I to Week 36 Tanner II | 1 | Participants | |
| Change From Baseline in TS of Pubertal Development for Genital Growth to Week 12, Week 36, and Week 64 | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | BL Tanner I to Week 36 Tanner III | 8 | Participants | |
| Change From Baseline in TS of Pubertal Development for Genital Growth to Week 12, Week 36, and Week 64 | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | BL Tanner I to Week 36 Tanner IV | 1 | Participants | |
| Change From Baseline in TS of Pubertal Development for Genital Growth to Week 12, Week 36, and Week 64 | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | BL Tanner II to Week 36 Tanner II | 1 | Participants | |
| Change From Baseline in TS of Pubertal Development for Genital Growth to Week 12, Week 36, and Week 64 | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | BL Tanner I to Week 64 Tanner II | 1 | Participants | |
| Change From Baseline in TS of Pubertal Development for Genital Growth to Week 12, Week 36, and Week 64 | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | BL Tanner I to Week 64 Tanner III | 4 | Participants | |
| Change From Baseline in TS of Pubertal Development for Genital Growth to Week 12, Week 36, and Week 64 | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | BL Tanner I to Week 64 Tanner IV | 4 | Participants | |
| Change From Baseline in TS of Pubertal Development for Genital Growth to Week 12, Week 36, and Week 64 | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | BL Tanner I to Week 64 Tanner V | 2 | Participants | |
| Change From Baseline in TS of Pubertal Development for Genital Growth to Week 12, Week 36, and Week 64 | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | BL Tanner I to Week 64 Unknown | 1 | Participants | |
| Change From Baseline in TS of Pubertal Development for Genital Growth to Week 12, Week 36, and Week 64 | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | BL Tanner II to Week 64 Tanner III | 1 | Participants | |
| Mean Serum Concentration of CFA | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | Predose Day 1 | 0.0 | Standard Deviation 0.0 | ng/L |
| Mean Serum Concentration of CFA | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | Postdose Day 1 (6-24 hours) | 4100 | Standard Deviation 2630 | ng/L |
| Mean Serum Concentration of CFA | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | Postdose Day 3 (32-52 hours) | 5880 | Standard Deviation 1640 | ng/L |
| Mean Serum Concentration of CFA | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | Postdose Day 5 (72-120 hours) | 4240 | Standard Deviation 1180 | ng/L |
| Mean Serum Concentration of CFA | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | Postdose Day 8 (144-192 hours) | 2110 | Standard Deviation 864 | ng/L |
| Mean Serum Concentration of CFA | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | Postdose Day 11 (216-264 hours) | 1150 | Standard Deviation 655 | ng/L |
| Mean Serum Concentration of CFA | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | Predose Day 29 | 480 | Standard Deviation 348 | ng/L |
| Mean Serum Concentration of CFA | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | Predose Day 85 | 695 | Standard Deviation 1310 | ng/L |
| Mean Serum Concentration of CFA | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | Predose Day 169 | 691 | Standard Deviation 1060 | ng/L |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03019575/results?page=3